Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey

This study evaluated pneumococcal vaccination status using evaluable data collected from 445 of 1,313 managing directors of elderly care facilities in Japan through an online survey (September 5, 2022-November 25, 2022; UMIN000048747); comparisons were made with the influenza (2021–2022 vaccination...

Full description

Saved in:
Bibliographic Details
Main Authors: Youngju Kim, Hironori Taniguchi, Kotoba Okuyama, Junpei Kamimoto, Kenji Kawakami
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2461814
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206508850249728
author Youngju Kim
Hironori Taniguchi
Kotoba Okuyama
Junpei Kamimoto
Kenji Kawakami
author_facet Youngju Kim
Hironori Taniguchi
Kotoba Okuyama
Junpei Kamimoto
Kenji Kawakami
author_sort Youngju Kim
collection DOAJ
description This study evaluated pneumococcal vaccination status using evaluable data collected from 445 of 1,313 managing directors of elderly care facilities in Japan through an online survey (September 5, 2022-November 25, 2022; UMIN000048747); comparisons were made with the influenza (2021–2022 vaccination only) and coronavirus disease 2019 (COVID-19) vaccination status. Among facilities who kept pneumococcal vaccination records (n = 42), the mean pneumococcal vaccination rate was 31.1%, with the rate being higher for the influenza (93.1%; n = 234) and COVID-19 (94.3%; n = 285) vaccines. Overall, excluding facilities that answered that the corresponding vaccine status at their sites was unknown, the percentage of facilities with high vaccination rates (80% to 100%) was substantially higher for the influenza (80.5%; 351/436) and COVID-19 (89.6%; 396/442) vaccines than for the pneumococcal vaccine (6.5%; 24/370). Multivariable analysis showed that major factors associated with a high pneumococcal vaccination rate (≥15%) were “managing director’s willingness to recommend” and “pneumococcal vaccination request from the residents.” The most common reason for their willingness to recommend the pneumococcal vaccine was that it is an effective disease prevention strategy (83.3%; 65/78) and for their unwillingness to recommend the pneumococcal vaccine was the inability to understand the effectiveness of the vaccine (43.6%; 17/39). In conclusion, there is a need to improve pneumococcal vaccination rates in elderly care facilities in Japan. Strategies such as increasing awareness and encouraging pneumococcal vaccine recommendation among managing directors, especially for residents not eligible for the national subsidy program, and providing regular training on the pneumococcal vaccine for staff and residents are required.
format Article
id doaj-art-b81c0d52fbc94a2fa35d747373b09f0b
institution Kabale University
issn 2164-5515
2164-554X
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj-art-b81c0d52fbc94a2fa35d747373b09f0b2025-02-07T08:49:03ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2025-12-0121110.1080/21645515.2025.2461814Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based surveyYoungju Kim0Hironori Taniguchi1Kotoba Okuyama2Junpei Kamimoto3Kenji Kawakami4Medical Affairs, MSD K. K., Tokyo, JapanMedical Affairs, MSD K. K., Tokyo, JapanMedical Affairs, MSD K. K., Tokyo, JapanMedical Affairs, MSD K. K., Tokyo, JapanDepartment of Internal Medicine, NTT East Izu Hospital, Shizuoka, JapanThis study evaluated pneumococcal vaccination status using evaluable data collected from 445 of 1,313 managing directors of elderly care facilities in Japan through an online survey (September 5, 2022-November 25, 2022; UMIN000048747); comparisons were made with the influenza (2021–2022 vaccination only) and coronavirus disease 2019 (COVID-19) vaccination status. Among facilities who kept pneumococcal vaccination records (n = 42), the mean pneumococcal vaccination rate was 31.1%, with the rate being higher for the influenza (93.1%; n = 234) and COVID-19 (94.3%; n = 285) vaccines. Overall, excluding facilities that answered that the corresponding vaccine status at their sites was unknown, the percentage of facilities with high vaccination rates (80% to 100%) was substantially higher for the influenza (80.5%; 351/436) and COVID-19 (89.6%; 396/442) vaccines than for the pneumococcal vaccine (6.5%; 24/370). Multivariable analysis showed that major factors associated with a high pneumococcal vaccination rate (≥15%) were “managing director’s willingness to recommend” and “pneumococcal vaccination request from the residents.” The most common reason for their willingness to recommend the pneumococcal vaccine was that it is an effective disease prevention strategy (83.3%; 65/78) and for their unwillingness to recommend the pneumococcal vaccine was the inability to understand the effectiveness of the vaccine (43.6%; 17/39). In conclusion, there is a need to improve pneumococcal vaccination rates in elderly care facilities in Japan. Strategies such as increasing awareness and encouraging pneumococcal vaccine recommendation among managing directors, especially for residents not eligible for the national subsidy program, and providing regular training on the pneumococcal vaccine for staff and residents are required.https://www.tandfonline.com/doi/10.1080/21645515.2025.2461814COVID-19 vaccinationelderly care facility residentsinfluenza vaccinationJapanpneumococcal vaccinationvaccination rate
spellingShingle Youngju Kim
Hironori Taniguchi
Kotoba Okuyama
Junpei Kamimoto
Kenji Kawakami
Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey
Human Vaccines & Immunotherapeutics
COVID-19 vaccination
elderly care facility residents
influenza vaccination
Japan
pneumococcal vaccination
vaccination rate
title Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey
title_full Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey
title_fullStr Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey
title_full_unstemmed Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey
title_short Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey
title_sort pneumococcal vaccination in elderly care facilities in japan a cross sectional web based survey
topic COVID-19 vaccination
elderly care facility residents
influenza vaccination
Japan
pneumococcal vaccination
vaccination rate
url https://www.tandfonline.com/doi/10.1080/21645515.2025.2461814
work_keys_str_mv AT youngjukim pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey
AT hironoritaniguchi pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey
AT kotobaokuyama pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey
AT junpeikamimoto pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey
AT kenjikawakami pneumococcalvaccinationinelderlycarefacilitiesinjapanacrosssectionalwebbasedsurvey